Slow clinical improvement after treatment initiation in Leishmania/HIV coinfected patients

INTRODUCTION: In Brazil there is a large area of overlap of visceral leishmaniasis (VL) and HIV infection, which favored a increased incidence of coinfection Leishmania/HIV. METHODS: This study evaluated 65 consecutive patients with VL and their clinical response to treatment in two health care sett...

Full description

Bibliographic Details
Main Authors: Guenael Freire de Souza, Fernando Biscione, Dirceu Bartolomeu Greco, Ana Rabello
Format: Article
Language:English
Published: Sociedade Brasileira de Medicina Tropical (SBMT) 2012-04-01
Series:Revista da Sociedade Brasileira de Medicina Tropical
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822012000200001&lng=en&tlng=en
_version_ 1818232597232222208
author Guenael Freire de Souza
Fernando Biscione
Dirceu Bartolomeu Greco
Ana Rabello
author_facet Guenael Freire de Souza
Fernando Biscione
Dirceu Bartolomeu Greco
Ana Rabello
author_sort Guenael Freire de Souza
collection DOAJ
description INTRODUCTION: In Brazil there is a large area of overlap of visceral leishmaniasis (VL) and HIV infection, which favored a increased incidence of coinfection Leishmania/HIV. METHODS: This study evaluated 65 consecutive patients with VL and their clinical response to treatment in two health care settings in Belo Horizonte, Brazil. RESULTS: At baseline, the clinical picture was similar between both groups, although diarrhea and peripheral lymphadenomegaly were more frequent in HIV-infected subjects. HIV-positive patients had lower median blood lymphocyte counts (686/mm³ versus 948/mm³p = 0.004) and lower values of alanine aminotransferase (ALT) (48IU/L versus 75.6IU/L p = 0.016) than HIV-negative patients. HIV-positive status (hazard ratio = 0.423, p = 0.023) and anemia (HR = 0.205, p = 0.002) were independent negative predictors of complete clinical response following antileishmanial treatment initiation. CONCLUSIONS: This study reinforces that all patients with VL should be tested for HIV infection, regardless of their clinical picture. This practice would allow early recognition of coinfection with initiation of antiretroviral therapy and, possibly, reduction in treatment failure.
first_indexed 2024-12-12T11:08:49Z
format Article
id doaj.art-ba9dde46554b456b86912d065e81430f
institution Directory Open Access Journal
issn 1678-9849
language English
last_indexed 2024-12-12T11:08:49Z
publishDate 2012-04-01
publisher Sociedade Brasileira de Medicina Tropical (SBMT)
record_format Article
series Revista da Sociedade Brasileira de Medicina Tropical
spelling doaj.art-ba9dde46554b456b86912d065e81430f2022-12-22T00:26:21ZengSociedade Brasileira de Medicina Tropical (SBMT)Revista da Sociedade Brasileira de Medicina Tropical1678-98492012-04-0145214715010.1590/S0037-86822012000200001S0037-86822012000200001Slow clinical improvement after treatment initiation in Leishmania/HIV coinfected patientsGuenael Freire de Souza0Fernando Biscione1Dirceu Bartolomeu Greco2Ana Rabello3Universidade Federal de Minas GeraisUniversidade Federal de Minas GeraisUniversidade Federal de Minas GeraisFundação Oswaldo CruzINTRODUCTION: In Brazil there is a large area of overlap of visceral leishmaniasis (VL) and HIV infection, which favored a increased incidence of coinfection Leishmania/HIV. METHODS: This study evaluated 65 consecutive patients with VL and their clinical response to treatment in two health care settings in Belo Horizonte, Brazil. RESULTS: At baseline, the clinical picture was similar between both groups, although diarrhea and peripheral lymphadenomegaly were more frequent in HIV-infected subjects. HIV-positive patients had lower median blood lymphocyte counts (686/mm³ versus 948/mm³p = 0.004) and lower values of alanine aminotransferase (ALT) (48IU/L versus 75.6IU/L p = 0.016) than HIV-negative patients. HIV-positive status (hazard ratio = 0.423, p = 0.023) and anemia (HR = 0.205, p = 0.002) were independent negative predictors of complete clinical response following antileishmanial treatment initiation. CONCLUSIONS: This study reinforces that all patients with VL should be tested for HIV infection, regardless of their clinical picture. This practice would allow early recognition of coinfection with initiation of antiretroviral therapy and, possibly, reduction in treatment failure.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822012000200001&lng=en&tlng=enLeishmaniose visceralHIVCo-infecçãoTratamento
spellingShingle Guenael Freire de Souza
Fernando Biscione
Dirceu Bartolomeu Greco
Ana Rabello
Slow clinical improvement after treatment initiation in Leishmania/HIV coinfected patients
Revista da Sociedade Brasileira de Medicina Tropical
Leishmaniose visceral
HIV
Co-infecção
Tratamento
title Slow clinical improvement after treatment initiation in Leishmania/HIV coinfected patients
title_full Slow clinical improvement after treatment initiation in Leishmania/HIV coinfected patients
title_fullStr Slow clinical improvement after treatment initiation in Leishmania/HIV coinfected patients
title_full_unstemmed Slow clinical improvement after treatment initiation in Leishmania/HIV coinfected patients
title_short Slow clinical improvement after treatment initiation in Leishmania/HIV coinfected patients
title_sort slow clinical improvement after treatment initiation in leishmania hiv coinfected patients
topic Leishmaniose visceral
HIV
Co-infecção
Tratamento
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822012000200001&lng=en&tlng=en
work_keys_str_mv AT guenaelfreiredesouza slowclinicalimprovementaftertreatmentinitiationinleishmaniahivcoinfectedpatients
AT fernandobiscione slowclinicalimprovementaftertreatmentinitiationinleishmaniahivcoinfectedpatients
AT dirceubartolomeugreco slowclinicalimprovementaftertreatmentinitiationinleishmaniahivcoinfectedpatients
AT anarabello slowclinicalimprovementaftertreatmentinitiationinleishmaniahivcoinfectedpatients